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South Africa’s disease burden
Doctors tend to be more turned on by the immediate health
problem of an individual, which can be analysed and a course
of logical action mapped out, than by population studies,
which we tend to leave to the public health people, actuaries,
statisticians and the like. Just such a group has just completed
the first national burden of disease study for South Africa 
(p. 682). We had better take note of this important study, as it
provides startling data that will significantly influence health
care provision in the near future.
The authors note that burden of disease information is an
important component of health information required for health
planning, as it can be used to identify the health gaps in the
population that need to be addressed to improve health status.
Earlier analysis of South African mortality data identified an
unusual triple burden of disease, comprising pre-transitional
diseases and conditions related to poverty and under-
development, emerging chronic diseases, and injuries. This
pattern is changing to a quadruple burden as a result of the
HIV/AIDS epidemic.
There is a striking loss of years of life from HIV/AIDS (38%),
which is proportionately higher for females (47%) than for
males (33%). After HIV/AIDS (30%), cardiovascular disease
(16.6%), infectious and parasitic diseases (10.3%), malignant
neoplasms (7.5%), intentional injuries (7%) and unintentional
injuries are the leading cause-of-death categories. Males have a
higher proportion of injury deaths. South Africa’s injury rates
are higher than anywhere else in the world, due mainly to very
high rates of intentional injuries.
The study highlights that the already high disease burden
due to HIV/AIDS can be expected to grow rapidly in the next
few years unless interventions that delay mortality and
morbidity become widely available. Although additional
money for HIV/AIDS has been allocated in the budget, this
needs further attention as the almost 40% of premature
mortality due to HIV/AIDS in 2000 can be expected to increase
to 75% by 2010.
Interventions that are likely to reduce premature mortality
significantly in South Africa include:
• Reduce HIV transmission and delay mortality from AIDS in
adults by improving treatment of sexually transmitted
infections, improving voluntary counselling and testing
services, providing antiretroviral treatment to pregnant HIV-
positive women and HIV-positive patients, and promoting
safe sex.
• Improve TB control.
• Promote healthy lifestyles, including a prudent diet, physical
activity and reduced smoking, alcohol and substance abuse.
Lung cancer and the adrenals
Medical students learn that the adrenals provide fertile ground
for the growing of metastases from some cancers. Ross et al.
(p. 695) aimed to determine the prevalence of primary
hypoadrenalism in patients with stage 3 and 4 lung cancer.
Lung cancer is the leading cause of cancer mortality in most
countries. The adrenal glands are common sites of metastases,
as proven by autopsies, which reported adrenal metastases in
more than 40% of patients with bronchogenic carcinoma. This
high prevalence may be due to the rich sinusoidal blood
supply and high local concentration of glucocorticoids, which
may promote implanting of metastases. Despite the high
frequency of adrenal metastases in patients with bronchogenic
carcinoma, the prevalence of hypoadrenalism is poorly
documented, although there have been reports of adrenal
insufficiency as the sole manifestation of cancer and of
malignancies initially presenting as Addisonian crises.
The authors studied biochemical and clinical predictors of
hypoadrenalism and found that clinically relevant
hypoadrenalism is distinctly uncommon. Furthermore,
electrolyte disturbances and basal cortisol concentrations are of
limited use in identifying the occasional patient with mild
hypoadrenalism.
Renal transplantation — impact
of gender, age and race
The SAMJ has a policy of carefully considering articles that
purport to find differing results of treatment on the basis of
race. Many of these in fact turn out to be due to other factors
such as socioeconomic status. Gratuitous mention of race,
which has no bearing on the clinical problem, is unacceptable.
The article by Moosa (p. 689) was accepted because there were
findings in the world literature that appeared to implicate race
in the outcomes of renal transplantation.
In common with other developing countries, South Africa
has limited resources and only a fraction of patients with
irreversible renal failure receive treatment. In order to make
optimal use of these limited resources it is necessary to ensure
that all factors that can improve outcome are considered. The
study therefore looked specifically at the influence of
demographic factors on both patient survival and the survival
of renal allographs by studying the data of 542 patients
receiving primary renal allographs over a 23-year period.
The study showed that age is an important determinant of
outcome after renal transplantation but that race is not! The
data demonstrated the superiority of patient and graft survival
in younger patients. Gender does not influence graft survival,
but females do have a higher overall mortality rate following
renal transplantation at the University of Stellenbosch Renal
Unit, Tygerberg Hospital.
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